Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Total Liabilities: 2020-2024

Historic Total Liabilities for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to $169.1 million.

  • Oncology Institute's Total Liabilities rose 744.77% to $175.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $175.9 million, marking a year-over-year increase of 744.77%. This contributed to the annual value of $169.1 million for FY2024, which is 1111.13% up from last year.
  • As of FY2024, Oncology Institute's Total Liabilities stood at $169.1 million, which was up 1111.13% from $152.2 million recorded in FY2023.
  • Oncology Institute's 5-year Total Liabilities high stood at $169.1 million for FY2024, and its period low was $37.6 million during FY2020.
  • For the 5-year period, Oncology Institute's Total Liabilities averaged around $119.3 million, with its median value being $138.5 million (2022).
  • In the last 5 years, Oncology Institute's Total Liabilities soared by 16412.68% in 2021 and then skyrocketed by 991.05% in 2023.
  • Oncology Institute's Total Liabilities (Annual) stood at $37.6 million in 2020, then surged by 164.13% to $99.3 million in 2021, then skyrocketed by 39.49% to $138.5 million in 2022, then grew by 9.91% to $152.2 million in 2023, then rose by 11.11% to $169.1 million in 2024.
  • Its last three reported values are $169.1 million in FY2024, $152.2 million for FY2023, and $138.5 million during FY2022.